OTTAWA, March 19, 2013 /CNW/ - Botaneco Corp. (the "Company") (TSXV: BOT), a leading natural specialty ingredients company providing key ingredients to the food and personal care industries announces today that its subsidiary Natunola Health Biosciences Inc. ("NHB") has entered into an agreement with Avrio Ventures Limited Partnership ("Avrio") to extended the maturity date of the subordinated debenture in the principle amount of $500,000 (the "Debenture") issued by NHB to Avrio on March 22, 2011. The Debenture was scheduled to mature on March 23, 2013. The maturity date has now been extended to March 23, 2014. The other terms of the Debenture remain unchanged.
The Company is pleased to have this extension as this will help the Company maintain and preserve liquidity, so it can focus on continued business, operations and growth in Natunola Health Inc., a wholly-owned subsidiary of the Company based in Winchester, Ontario.
About the Company:
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Botaneco Corp.
For further information: